Table 1 The clinicopathological parameters of colorectal cancer patients in TCGA
From: Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment
Subtype | CS1 (n = 227) | CS2 (n = 283) | p |
|---|---|---|---|
Age | 64.71 ± 13.44 | 66.09 ± 12.53 | 0.236 |
Gender (%) | Â | Â | Â |
 Female | 107 (47.1) | 136 (48.1) | 0.906 |
 Male | 120 (52.9) | 147 (51.9) | |
M stage (%) | Â | Â | Â |
 M0 | 160 (70.5) | 208 (73.5) | 0.654 |
 M1 | 37 (16.3) | 39 (13.8) | |
 MX | 28 (12.3) | 31 (11.0) | |
 Unknown | 2 (0.9) | 5 (1.8) |  |
N stage (%) | Â | Â | Â |
 N0 | 114 (50.2) | 175 (61.8) | 0.005 |
 N1 | 56 (24.7) | 70 (24.7) | |
 N2 | 56 (24.7) | 38 (13.4) | |
 NX | 1 (0.4) | 0 (0.0) |  |
T stage (%) | Â | Â | Â |
 T1 | 5 (2.2) | 14 (4.9) | 0.001 |
 T2 | 24 (10.6) | 66 (23.3) | |
 T3 | 168 (74.0) | 176 (62.2) | |
 T4 | 30 (13.2) | 26 (9.2) | |
 Tis | 0 (0.0) | 1 (0.4) |  |
Stage (%) | Â | Â | Â |
 Stage I | 25 (11.0) | 66 (23.3) | 0.008 |
 Stage II | 82 (36.1) | 97 (34.3) | |
 Stage III | 74 (32.6) | 73 (25.8) | |
 Stage IV | 38 (16.7) | 39 (13.8) | |
 Unknown | 8 (3.5) | 8 (2.8) |  |
Cancer type (%) | Â | Â | Â |
 Colon adenocarcinoma | 137 (60.4) | 186 (65.7) | 0.247 |
 Colorectal adenocarcinoma | 2 (0.9) | 0 (0.0) |  |
 Mucinous adenocarcinoma of the colon and rectum | 29 (12.8) | 28 (9.9) | |
 Rectal adenocarcinoma | 59 (26.0) | 69 (24.4) | |
Longest dimension (cm) | 1.38 ± 0.61 | 1.17 ± 0.50 | 0.001 |
Disease-free status (%) | Â | Â | |
 Disease free | 133 (69.6) | 209 (82.9) | 0.001 |
 Recurred/progressed | 58 (30.4) | 43 (17.1) | |